chloasma and postinflammatory hyperpigmentation
Conditions
Interventions
Experimental group (Melasma/ Postinflammatory hyperpigmentation):Using test products
Sponsors
West China Hospital, Sichuan University
Eligibility
Sex/Gender
Female
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1) 18 years old and above, female; 2) There is pigmentation that meets the clinical diagnostic criteria for melasma or is diagnosed as postinflammatory hyperpigmentation; 3) No recent family planning; 4) Persisting in completing the entire course of treatment; 5) High compliance; 6) During the treatment and follow-up period, no other diseases were treated simultaneously.
Exclusion criteria
Exclusion criteria: 1) Within 6 months have been oral or topical retinoic acid, hormones, tranexamic acid, and other drugs; 2) Suffering from other types of skin diseases; 3) Pregnant women or severe cardiovascular, liver, and kidney diseases; 4) In the past 3 months, laser, intense pulsed light, and chemical peeling agent systems have been used to treat chloasma or postinflammatory hyperpigmentation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Redness;skin color; | — |
Secondary
| Measure | Time frame |
|---|---|
| Loss of moisture through the epidermis;Skin stratum corneum moisture content;Security assessment; | — |
Countries
China
Contacts
Public ContactWang Xi
West China Hospital, Sichuan University
Outcome results
None listed